sinemet- carbidopa and levodopa tablet
merck sharp & dohme corp. - carbidopa (unii: mnx7r8c5vo) (carbidopa anhydrous - unii:kr87b45rgh), levodopa (unii: 46627o600j) (levodopa - unii:46627o600j) - carbidopa anhydrous 10 mg - sinemet is indicated in the treatment of parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. carbidopa allows patients treated for parkinson's disease to use much lower doses of levodopa. some patients who responded poorly to levodopa have improved on sinemet. this is most likely due to decreased peripheral decarboxylation of levodopa caused by administration of carbidopa rather than by a primary effect of carbidopa on the nervous system. carbidopa has not been shown to enhance the intrinsic efficacy of levodopa. carbidopa may also reduce nausea and vomiting and permit more rapid titration of levodopa. nonselective monoamine oxidase (mao) inhibitors are contraindicated for use with sinemet. these inhibitors must be discontinued at least two weeks prior to initiating therapy with sinemet. sinemet may be administered concomitantly with the manufacturer's recommended dose of an mao inhibitor with selectivity for
sinemet 250/25 levodopa/carbidopa 250mg/25mg tablet bottle
merck sharp & dohme (australia) pty ltd - carbidopa monohydrate,levodopa -
sinemet 100/25 levodopa/carbidopa 100 mg/25 mg tablet bottle
merck sharp & dohme (australia) pty ltd - carbidopa monohydrate,levodopa -
sinemet plus
b & s healthcare - levodopa carbidopa - tablets - 25/100 milligram
sinemet cr 50/200 milligram tablet prolonged release
pco manufacturing - levodopa, carbidopa - tablet prolonged release - 50/200 milligram - dopa and dopa derivatives
sinemet tablet 25/100 mg
merck sharp & dohme (malaysia) sdn bhd - carbidopa; levodopa -
sinemet tablet 25/250 mg
merck sharp & dohme (malaysia) sdn bhd - carbidopa; levodopa -
ran-ropinirole tablet
ranbaxy pharmaceuticals canada inc. - ropinirole (ropinirole hydrochloride) - tablet - 0.25mg - ropinirole (ropinirole hydrochloride) 0.25mg - nonergot-derivative dopamine receptor agonists
teva-ropinirole tablet
teva canada limited - ropinirole (ropinirole hydrochloride) - tablet - 0.25mg - ropinirole (ropinirole hydrochloride) 0.25mg - nonergot-derivative dopamine receptor agonists